GFM
INBX icon

GF Fund Management’s Inhibrx INBX Stock Holding History

GF Fund Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9K Buy
326
+41
+14% +$3.04K ﹤0.01% 490
2025
Q4 		$22.5K Sell
285
-22
-7% -$1.5K ﹤0.01% 492
2025
Q3 		$10.3K Sell
307
-52
-14% -$1.28K ﹤0.01% 554
2025
Q2 		$5.12K Hold
359
– – ﹤0.01% 623
2025
Q1 		$5.02K Buy
359
+55
+18% +$747 ﹤0.01% 624
2024
Q4 		$4.68K Buy
+304
New +$4.63K ﹤0.01% 612

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

GF Fund Management's INBX Position: Q1 2026 in Review

GF Fund Management increased its Inhibrx (INBX) stake by 14% in Q1 2026, buying an estimated $3.04K and bringing the position to 326 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

GF Fund Management first reported a position in INBX in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.5K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • GF Fund Management held 326 shares of Inhibrx worth $21.9K as of Q1 2026.
  • GF Fund Management bought 41 Inhibrx shares in Q1 2026, an estimated $3.04K.
  • Inhibrx made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #490 holding.
  • GF Fund Management first reported a position in Inhibrx in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Inhibrx position peaked at $22.5K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.